Supernova

This study is testing the effectiveness of a new drug to prevent COVID-19.

It is being carried out in Greater Manchester by a team of researchers at Manchester University NHS Foundation Trust.

Criteria

  • aged 18-55
  • No COVID-19 infection in the past 6 months
  • No COVID-19 vaccination in the past 3 months
  • No history of cancer/malignancy within the past 5 years

Location

  • Manchester Royal Infirmary (part of Manchester University NHS Foundation Trust)

Involves

Taking part will involve:

  • Attending 11 clinic visits over a 12-month period
  • The study drug will be given at one visit via intramuscular injection*
  • Visits will include a range of tests (eg blood samples, heart and blood pressure checks) as well as questions about lifestyle and medical history

Participants will receive a payment of £50 for each onsite visit, plus reasonable travel expenses.

* Participants will be randomly selected to receive either the study drug or a placebo.

Recruiting until

  • 28 February 2023

Want to take part or learn more?